PLANTARC BIO LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 258.4 ILa | -4.30% |
|
-7.85% | -23.30% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2021 | - | Sales 2022 | 0.1 37.04 | Capitalization | 26.2M 9.71B |
|---|---|---|---|---|---|
| Net income 2021 | -6M -2.22B | Net income 2022 | -4M -1.48B | EV / Sales 2021 | - |
| Net cash position 2021 | 17.65 6.54K | Net cash position 2022 | 14.24 5.27K | EV / Sales 2022 | 261,993,888 x |
| P/E ratio 2021 |
-3.85
x | P/E ratio 2022 |
-5.24
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 42.95% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.30% | ||
| 1 week | -7.85% | ||
| Current month | -6.04% | ||
| 1 month | -4.65% | ||
| 3 months | -28.72% | ||
| 6 months | -32.00% | ||
| Current year | -23.30% |
1 week
243.10
272.00
1 month
243.10288.10
Current year
243.10390.00
1 year
243.10750.00
3 years
243.101 460.00
5 years
243.101 950.00
10 years
243.101 950.00
| Managers | Title | Age | Since |
|---|---|---|---|
Dror Shalitin
FOU | Founder | 59 | 14-05-14 |
| Director of Finance/CFO | 60 | 20-09-14 | |
| Corporate Officer/Principal | 51 | 21-12-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ofra Yamin
BRD | Director/Board Member | 61 | 21-03-21 |
Oded Shoseyov
CHM | Chairman | 67 | 16-12-31 |
Avi Zigelman
BRD | Director/Board Member | 67 | 21-03-21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 258.4 | -4.30% | 37,986 |
| 24-05-15 | 270 | -0.74% | 900 |
| 24-05-12 | 272 | -3.00% | 22,758 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 16, 2024 at 10:24 am EDT
More quotes
Plantarc Bio Ltd is an Israel-based research and development company. Plantarc Bio Ltd operates as agricultural biotechnology (Ag-Bio) company and develops Direct-In-Plant (DIP) discovery platform which enables to discover and develop genes that has positive effects on plants, such as yield improvement, drought resistance and herbicide and insects tolerance. Company's platform allows scanning of millions of genes, at once and at scale, directly on plants, so it makes gene discovery more effective and efficient. Moreover the Company is engaged in in the development of RNAi based external applications for crop protection and yield enhancement and develops Cannabis Gene-Based Innovation and is focused on activities: production of active molecules (such as CBD/THC) in a bioreactor in large scale, and gene-editing in Cannabis to develop improved strains.
Sector
Fishing & Farming
- Stock Market
- Equities
- PLNT Stock